An Imaging Study of Polyvascular Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHarbin Medical University

About this trial

1. Establish a multimodality imaging database for PVD, improve the one-stop screening process for early PVD based on artificial intelligence, build a full-cycle control information platform, and promote the construction and standardization of a multidisciplinary co-morbidity and co-management diagnosis and treatment model. 2. Based on non-invasive, zero-contrast ocular OCTA combined with one-stop CTA imaging of the heart and brain, construct an integrated "eye-heart-brain" early warning model for PVD, and explore a potential non-invasive and convenient early warning system for PVD. 3. Based on the multi-omics, investigate EVs-mediated intercellular communication network, elucidate the roles and regulatory mechanisms of EVs in the development of PVD, search for potential targets for intervention, and construct an artificial intelligence-based "pan-vascular score" risk assessment system based on the combination of multi-modality imaging and multi-omics biomarkers.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with coronary artery disease (≥50% stenosis in any coronary artery on coronary angiography)

Age ≥18 years old

Proposed OCT-IVUS integrated imaging system

able to provide written informed consent prior to the start of any procedures related to the study.

Disqualifiers

severely tortuous/calcified coronary arteries with anticipated difficulty in completing the OCT-IVUS integrated imaging system

uncontrolled congestive heart failure or acute left heart failure;plan

claustrophobia;

left main stem occlusion;

Trial population

Patients with polyvascular disease in the 2nd Affiliated Hospital of Harbin Medical University

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Magnetic Resonance Angiography, Ocular OCTA, CT Angiography

    Diagnostic test

    Magnetic Resonance Angiography of intracranial artery, carotid artery, renal artery and lower extremity artery, CT angiography of coronary artery or intracranial artery

Treatment groups

1,100 Participants
are divided into 1 treatment group
Group A: Polyvascular disease1 intervention

Trial outcomes

Primary outcomes

1

Task1: MACE

All cause death, stroke, myocardial reinfarction, unplanned revascularization, lower extremity artery disease

Time frame
1 year
2

Task2: Plaque characteristics

Plaque morphology on OCT

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.